BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 25853132)

  • 1. Introduction to radiobiology of targeted radionuclide therapy.
    Pouget JP; Lozza C; Deshayes E; Boudousq V; Navarro-Teulon I
    Front Med (Lausanne); 2015; 2():12. PubMed ID: 25853132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From the target cell theory to a more integrated view of radiobiology in Targeted radionuclide therapy: The Montpellier group's experience.
    Pouget JP; Santoro L; Piron B; Paillas S; Ladjohounlou R; Pichard A; Poty S; Deshayes E; Constanzo J; Bardiès M
    Nucl Med Biol; 2022; 104-105():53-64. PubMed ID: 34922279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Radiobiology of Radiopharmaceuticals.
    Morris ZS; Wang AZ; Knox SJ
    Semin Radiat Oncol; 2021 Jan; 31(1):20-27. PubMed ID: 33246632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review on Tumor Control Probability (TCP) and Preclinical Dosimetry in Targeted Radionuclide Therapy (TRT).
    Spoormans K; Crabbé M; Struelens L; De Saint-Hubert M; Koole M
    Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Targeted Radiopharmaceutical Therapy and Immune Checkpoint Blockade: From Preclinical Advances to the Clinic.
    Bellavia MC; Patel RB; Anderson CJ
    J Nucl Med; 2022 Nov; 63(11):1636-1641. PubMed ID: 36215570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EANM position paper on the role of radiobiology in nuclear medicine.
    Aerts A; Eberlein U; Holm S; Hustinx R; Konijnenberg M; Strigari L; van Leeuwen FWB; Glatting G; Lassmann M
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3365-3377. PubMed ID: 33912987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of cancer cell responses to targeted radionuclide therapy (TRT) and external beam radiotherapy (EBRT).
    Grzmil M; Boersema P; Sharma A; Blanc A; Imobersteg S; Pruschy M; Picotti P; Schibli R; Behe M
    J Hematol Oncol; 2022 Aug; 15(1):123. PubMed ID: 36045419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developments in Combining Targeted Radionuclide Therapies and Immunotherapies for Cancer Treatment.
    Kerr CP; Grudzinski JJ; Nguyen TP; Hernandez R; Weichert JP; Morris ZS
    Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetry in nuclear medicine therapy: radiobiology application and results.
    Strigari L; Benassi M; Chiesa C; Cremonesi M; Bodei L; D'Andrea M
    Q J Nucl Med Mol Imaging; 2011 Apr; 55(2):205-21. PubMed ID: 21386791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.
    Chiesa C; Mira M; Maccauro M; Spreafico C; Romito R; Morosi C; Camerini T; Carrara M; Pellizzari S; Negri A; Aliberti G; Sposito C; Bhoori S; Facciorusso A; Civelli E; Lanocita R; Padovano B; Migliorisi M; De Nile MC; Seregni E; Marchianò A; Crippa F; Mazzaferro V
    Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1718-1738. PubMed ID: 26112387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor efficacy of
    Potluri HK; Ferreira CA; Grudzinski J; Massey C; Aluicio-Sarduy E; Engle JW; Kwon O; Marsh IR; Bednarz BP; Hernandez R; Weichert JP; McNeel DG
    J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining External Beam Radiation and Radionuclide Therapies: Rationale, Radiobiology, Results and Roadblocks.
    Abbott EM; Falzone N; Lenzo N; Vallis KA
    Clin Oncol (R Coll Radiol); 2021 Nov; 33(11):735-743. PubMed ID: 34544640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy.
    Jagodinsky JC; Jin WJ; Bates AM; Hernandez R; Grudzinski JJ; Marsh IR; Chakravarty I; Arthur IS; Zangl LM; Brown RJ; Nystuen EJ; Emma SE; Kerr C; Carlson PM; Sriramaneni RN; Engle JW; Aluicio-Sarduy E; Barnhart TE; Le T; Kim K; Bednarz BP; Weichert JP; Patel RB; Morris ZS
    Theranostics; 2021; 11(13):6120-6137. PubMed ID: 33995649
    [No Abstract]   [Full Text] [Related]  

  • 14. Radionuclides in radiation-induced bystander effect; may it share in radionuclide therapy?
    Widel M
    Neoplasma; 2017; 64(5):641-654. PubMed ID: 28592116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationales, evidence, and design considerations for fractionated radioimmunotherapy.
    DeNardo GL; Schlom J; Buchsbaum DJ; Meredith RF; O'Donoghue JA; Sgouros G; Humm JL; DeNardo SJ
    Cancer; 2002 Feb; 94(4 Suppl):1332-48. PubMed ID: 11877764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade.
    Patel RB; Hernandez R; Carlson P; Grudzinski J; Bates AM; Jagodinsky JC; Erbe A; Marsh IR; Arthur I; Aluicio-Sarduy E; Sriramaneni RN; Jin WJ; Massey C; Rakhmilevich AL; Vail D; Engle JW; Le T; Kim K; Bednarz B; Sondel PM; Weichert J; Morris ZS
    Sci Transl Med; 2021 Jul; 13(602):. PubMed ID: 34261797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular Response to Exponentially Increasing and Decreasing Dose Rates: Implications for Treatment Planning in Targeted Radionuclide Therapy.
    Solanki JH; Tritt T; Pasternack JB; Kim JJ; Leung CN; Domogauer JD; Colangelo NW; Narra VR; Howell RW
    Radiat Res; 2017 Aug; 188(2):221-234. PubMed ID: 28541775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid-derived suppressor cells attenuate the antitumor efficacy of radiopharmaceutical therapy using
    Muralidhar A; Hernandez R; Morris ZS; Comas Rojas H; Bio Idrissou M; Weichert JP; McNeel DG
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38663936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contest between internal and external-beam dosimetry: The Zeno's paradox of Achilles and the tortoise.
    Cicone F; Sjögreen Gleisner K; Sarnelli A; Indovina L; Gear J; Gnesin S; Kraeber-Bodéré F; Bischof Delaloye A; Valentini V; Cremonesi M
    Phys Med; 2024 Jan; 117():103188. PubMed ID: 38042710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation dosimetry for radionuclide therapy in a nonmyeloablative strategy.
    DeNardo GL; Siantar CL; DeNardo SJ
    Cancer Biother Radiopharm; 2002 Feb; 17(1):107-18. PubMed ID: 11915167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.